贝伐单抗与视网膜缺血 - Suppr

Bevacizumab and retinal ischemia.

作者信息

Neubauer Aljoscha S, Kook Daniel, Haritoglou Christos, Priglinger Siegfried G, Kampik Anselm, Ulbig Michael W, Ceklic Lala

出版信息

Ophthalmology. 2007 Nov;114(11):2096. doi: 10.1016/j.ophtha.2007.05.057.

DOI:10.1016/j.ophtha.2007.05.057

PMID:17980746

Abstract

摘要

相似文献

Bevacizumab and retinal ischemia.

Ophthalmology. 2007 Nov;114(11):2096. doi: 10.1016/j.ophtha.2007.05.057.

The article by Kook et al 1 on the 1-year effect of bevacizumab in patients with chronic diffuse diabetic macular edema (DME).

Retina. 2009 May;29(5):718-9; author reply 719-20. doi: 10.1097/IAE.0b013e3181a3b936.

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.

Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Retina. 2008 Jul-Aug;28(7):957-63. doi: 10.1097/IAE.0b013e3181754209.

The article by Kovach and Rosenfeld.

Retina. 2009 May;29(5):717; author reply 717-8. doi: 10.1097/IAE.0b013e31819ed6d1.

Bevacizumab and macular edema.

Ophthalmology. 2008 Mar;115(3):585. doi: 10.1016/j.ophtha.2007.10.017.

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf.

Management of Coats disease with bevacizumab in 2 patients.

Can J Ophthalmol. 2008 Apr;43(2):245-6. doi: 10.3129/i08-028.

Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.

Retina. 2009 Jan;29(1):27-32. doi: 10.1097/IAE.0b013e31818ba9de.

Comment of article by Matsumoto Y.

Retina. 2008 May;28(5):782; author reply 782-3. doi: 10.1097/IAE.0b013e31816a559a.

引用本文的文献

Correlation Between Macular Microstructural Changes with Disease Staging and Visual Acuity in Diabetic Retinopathy.

Int J Gen Med. 2025 May 20;18:2619-2628. doi: 10.2147/IJGM.S516938. eCollection 2025.

Peripheral and central capillary non-perfusion in diabetic retinopathy: An updated overview.

Front Med (Lausanne). 2023 Mar 23;10:1125062. doi: 10.3389/fmed.2023.1125062. eCollection 2023.

Hemodynamic Effects of Anti-Vascular Endothelial Growth Factor Injections on Optical Coherence Tomography Angiography in Diabetic Macular Edema Eyes.

Transl Vis Sci Technol. 2022 Oct 3;11(10):5. doi: 10.1167/tvst.11.10.5.

Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study.

Ophthalmol Ther. 2022 Apr;11(2):653-660. doi: 10.1007/s40123-022-00455-5. Epub 2022 Jan 28.

Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.

Eye (Lond). 2022 Apr;36(4):692-703. doi: 10.1038/s41433-021-01750-4. Epub 2021 Aug 18.

Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence.

J Diabetes Res. 2021 Feb 26;2021:6620122. doi: 10.1155/2021/6620122. eCollection 2021.

Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion.

Yonsei Med J. 2017 May;58(3):676-678. doi: 10.3349/ymj.2017.58.3.676.

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Medicine (Baltimore). 2017 Mar;96(10):e6263. doi: 10.1097/MD.0000000000006263.

[Diabetic maculopathy].

Ophthalmologe. 2015 Oct;112(10):871-83; quiz 884-6. doi: 10.1007/s00347-015-0127-2.

Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease.

Clin Ophthalmol. 2013;7:173-8. doi: 10.2147/OPTH.S37544. Epub 2013 Jan 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bevacizumab and retinal ischemia.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献